A1ZN34:BVMF
Astrazeneca Plc Bdr
157,06 R$
arrow_upward
+1,00%(+1,56) 1D
29 մյս, 16:56:00 GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1ZN34...
Open
157,06 R$
High
157,06 R$
Low
157,06 R$
Mkt. cap
286,58 մլրդ
Avg. vol.
167,00
Volume
7,00
52-wk high
190,40 R$
52-wk low
125,28 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
Open
157,06 R$
High
157,06 R$
Low
157,06 R$
Mkt. cap
286,58 մլրդ
Avg. vol.
167,00
Volume
7,00
52-wk high
190,40 R$
52-wk low
125,28 R$
Shares outstanding
1,55 մլրդ
No. of employees
96 հզր
News stories
From sources across the web
FirstWord Pharma
·
6 ժամ առաջ
AstraZeneca shares subgroup data behind amyloidosis aspirations
Yahoo! Finance Canada
·
11 ժամ առաջ
US bank sees positive risk-reward for AstraZeneca ahead of pivotal heart drug trial
TipRanks
·
12 ժամ առաջ
CSPC Receives US$1.2 Billion Upfront from AstraZeneca in Peptide Drug Alliance
Traders Union
·
18 ժամ առաջ
AstraZeneca stock price forecast: GBX14,000–GBX14,300 resistance as AZN trades flat
Profile
AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation.
The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US.
AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje. Wikipedia
About Astrazeneca Plc Bdr
CEOPascal Soriot
Employees96,1 հզր
Founded06 ապր, 1999 թ.
HeadquartersՔեմբրիջ, Cambridgeshire, Միացյալ Թագավորություն
Sector-
Websiteastrazeneca.com
AI content may include mistakes. Learn more